Relievant Medsystems announced today that two new Category I Current Procedural Terminology (CPT) codes are now in effect for Intracept. Minneapolis-based Relievant designed its Intracept device and procedure to treat chronic low back pain (CLBP) from degenerative disc disease with Modic changes. It involves a minimally invasive procedure that targets the basivertebral nerve with radiofrequency-based […]
Relievant Medsystems
Relievant back-pain device study stopped for positive results
Relievant Medsystems said it has halted enrollment in a clinical trial of its Intracept lower-back pain device due to the device’s superiority over non-surgical management. The Level I Intracept study found a “highly significant reduction” in the Oswestry Disability Index (ODI) score in patients treated with the Intracept procedure over patients in the non-surgical management arm. The […]
Medtech companies raised more than $738 million in Q2
Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. […]
